Molly Trachtenberg
Acute Care · Boston, MANPI 1972151488
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.9%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Pulmonx Corporation at 47.6% of the total. Among acute care clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 23 payments — averaging $134.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pulmonx Corporation$1K
- Pinnacle Biologics, Inc$843
- Cook Incorporated$315
- Olympus America Inc.$150
- Boston Scientific$145
- Cook Medical LLC$93
- plus $81 from 1 others
What the payments were for
- Consulting fees$31510%
- Travel & lodging$1,27041%
- Food & beverage$1,51849%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pulmonx Corporation | 9 | $1,476 |
| Pinnacle Biologics, Inc | 7 | $843 |
| Cook Incorporated | 2 | $315 |
| Olympus America Inc. | 1 | $150 |
| Boston Scientific | 2 | $145 |
| Cook Medical LLC | 1 | $93 |
| Intuitive Surgical | 1 | $81 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,103 in reported general payments places this provider in the 90th percentile of 307 acute care providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amitriptyline Hcl | 11 | $23 |
Paid to pharmacies, not to this prescriber.
Other acute care in Boston
- Bridgid JosephBoston$110K
- Pamela CalareseBoston$106K
- Kimberly GuiboneBoston$86K
- Dawn NaylorBoston$13K
- Rebecca RathburnBoston$13K
- Morgan BowdenBoston$11K
- Javier RiveraBoston$11K
- Linda OrdwayBoston$7K
- Rebecca LongoBoston$7K
- Erin PearsonBoston$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.